1101 Pennsylvania Avenue NW
Suite 300
Washington, DC 20004
United States
202 756 2245
https://aspisotopes.com
Sektor(en): Basic Materials
Branche: Chemicals
Vollzeitmitarbeiter: 76
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Paul Elliot Mann | President, CEO & Executive Chairman | 260k | N/A | 1977 |
Mr. Robert Ainscow | CFO & COO | 133,33k | N/A | 1977 |
Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. | CTO & Director | 240k | N/A | 1961 |
ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
ASP Isotopes Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.